Yajun Liu

Yajun Liu has a diverse work experience spanning from 2008 to 2022. Starting as a Graduate Research Assistant at the University of Michigan, they focused on investigating microclimate pH kinetics in long-acting injectables. Yajun then joined Merck as a Postdoctoral Research Fellow before moving on to work at the FDA. At the FDA, Yajun served as a Bioequivalence Reviewer and later as a Senior Clinical Pharmacology Reviewer, specializing in the field of oncology. Currently, they hold the position of Director of Clinical Pharmacology at Repare Therapeutics.

Yajun Liu completed a Ph.D in Pharmaceutical Sciences from the University of Michigan between 2008 and 2013. Prior to that, from 2005 to 2008, they earned an M.S degree in Pharmaceutics from Shanghai Jiao Tong University. Yajun Liu began their education journey at Shanghai Jiao Tong University in 2001, where they obtained a B.S degree in Pharmacy, which took them four years to complete.